Get Updated

To Our Customers, Collaborators, Partners & Business Family

Thank you for your continued support of the New Objective family and for your patience as we work through our current backlog of orders. We deeply appreciate your trust in the quality of our products, and will continue to provide reliable, reproduceable products for the valuable research
that you perform.

The global crisis associated with the COVID-19 pandemic has impacted both our industry and the New Objective team. It has been a unique and unsettling time for all of us. Since the pandemic has become a new reality in our daily lives, we have continued to operate with human health and safety in mind. This safety is extended to everyone, including our teams at New Objective, partners, collaborators, and customers – as well as all of their families on the frontline. We extend our hope and compassion to all as we work through this crisis together.

To maintain the health and safety of the New Objective family, we are proud to formally announce the build out our new state-of-the-art manufacturing facility in Littleton, MA. At the new facility, we are able to segment manufacturing processes to maintain current social distancing requirements – keeping everyone safe and healthy. It is vitally important for us to follow safety procedures so we may have continued operations to produce high-quality products. This new site is dedicated to growing manufacturing capacity – following the same quality control process expected by our customers, partners, and business family. Moving into 2021, we are hiring and continuing to grow our team to increase capacity.

The challenges that we face as an industry during 2020 has forced everyone to think, re-think, and reset business practices. We continue to hear your feedback and will continue to support and enable our collaborators, partners, and customers that lead research and innovation related to COVID-19, vaccines, and therapies for different disease. As part of the 2020 business reset, we have dedicated resources to 6 Standard Platforms:

GlassTip TM | SilicaTip TM | PicoFrit ® Columns | TaperTip TM | PicoChip ® Kits | FlowChip ® Kits

Feedback indicates that our patented PicoFrit ®  LCMS columns provide The Ultimate LC-MS Platform for bottom-up proteomics applications related to drug discovery and mechanism of action for pathogens (see suggested literature related to COVID-19 Community Response).

PicoFrit ®  Technology leads the field in ruggedness and reliability – providing reproduceable results.As well, PicoFrit ®  Technology features a packed column integrated into the emitter, which translates into spraying directly off the column.  Spraying directly off the column eliminates nonspecific binding, often seen with other column-emitter designs.

Thank you again for your trust in New Objective – and stay safe and healthy. If you have any comments or questions, please reach out to Helena Svodobova at helena.svobodova@newobjective.com or Romi Elfakih at romi.elfakih@newobjective.com.

Data collected in collaboration with Susan Weintraub, University of Texas Medical Center, San Antonio, TX – 2002

Suggested Literature for Community COVID-19 Response – Nano Flow LC MS Applications

Gordon, D.E., Jang, G.M., Bouhaddou, M. et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature, 583, 459–468 (2020).

Gordan, D.E., Hiatt, J., Bouhaddou, M. et al. “Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.” Science, 370, (2020).